ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS
批准号:
10626232
负责人:
Maureen J Donlin
金额:
$36.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-26 至 2023-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cryptococcus neoformans is a pathogenic fungus that is found world-wide and causes
meningioencephalitis, particularly in immunocompromised individuals. It is invariably fatal unless
treated, and the current antifungals are inadequate to effectively cure this disease, due to
inherent toxicities, the inability to kill the fungus and prevent relapse, or innate resistance to the
class of antifungals. Recent studies have indicated that there are over 1,000,000 new cases of
cryptococcosis in the world each year, which results in over 600,000 deaths. New agents to
treat Cryptococcus are needed, and the fungal cell wall is an attractive target, since it is unique
to fungi and absent in humans. Echinocandins are a class of antifungals that target glucan
synthesis in the cell wall. Cryptococcus is naturally resistant to the echinocandins. We have
shown that disruption of the cell wall integrity (CWI) signaling pathway causes Cryptococcus to
become highly sensitive to echinocandins, and identified candidate transcription factors that
may play a role in echinocandin resistance. This pathway is the major pathway that impacts cell
wall and is dependent on protein kinase C (Pkc1). The CWI/PKC1 pathway plays a key role in
response to heat shock, oxidative and nitrosative stress, and cell wall inhibitors. Our preliminary
data suggests that this pathway is part of a highly connected network that controls cell wall
biosynthesis, repair and remodeling. The major goal of this project is to define the
mechanism(s) by which cell wall integrity is maintained in response to specific cell wall
inhibitors, including echinocandins and to identify potential gene targets for antifungals with
synergy to echinocandins. There are three specific aims: In the first aim, we will define the role
of the cell wall integrity pathway in echinocandin resistance using genomic and network analysis
approaches. In the second aim, we will identify the genes essential to cell wall integrity and that
contribute to echinocandin resistance by screening large deletion sets for specific phenotypes.
In the third aim, we will assess the functional interactions of the cell wall integrity components.
In this highly collaborative project, we propose to use our complementary expertise to integrate
genetic, phenotypic and biochemical data to identify and characterize the network of interactions
governing cell wall homeostasis in C. neoformans. This will significantly advance our
understanding of cell wall maintenance and remodeling in a human pathogen and will provide
multiple targets for designing specific antifungal drugs that are less likely to be toxic in
mammals.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/acsomega.1c00273
发表时间:
2021-03-30
期刊:
ACS omega
影响因子:
4.1
作者:
[Lin J, Zangi M, Kumar TVNH, Shakar Reddy M, Reddy LVR, Sadhukhan SK, Bradley DP, Moreira-Walsh B, Edwards TC, O'Dea AT, Tavis JE, Meyers MJ, Donlin MJ]
通讯作者:
Donlin MJ
Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of Cryptococcus neoformans and Cryptococcus gattii.
发现 5-Nitro-6-thiocyanatopyrimidines 作为新型隐球菌和格特隐球菌的抑制剂。
DOI:
10.1021/acsmedchemlett.1c00038
发表时间:
2021
期刊:
ACS medicinal chemistry letters
影响因子:
4.2
作者:
[Donlin,MaureenJ, Lane,ThomasR, Riabova,Olga, Lepioshkin,Alexander, Xu,Evan, Lin,Jeffrey, Makarov,Vadim, Ekins,Sean]
通讯作者:
Ekins,Sean
DOI:
10.1128/msphere.00134-22
发表时间:
2022-08-31
期刊:
mSphere
影响因子:
4.8
作者:
[]
通讯作者:
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS
-
批准号:9237001
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2017
-
负责人:Maureen J Donlin
-
依托单位:
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS
-
批准号:9927587
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:Maureen J Donlin
-
依托单位:
MUTATOR TRANSPOSON DEVELOPMENTAL REGULATION
-
批准号:2170371
-
项目类别:
-
资助金额:$1.43万
-
财政年份:1994
-
负责人:Maureen J Donlin
-
依托单位:
ANALYSIS OF MUTATOR TRANSPOSON DEVELOPMENTAL REGULATION
-
批准号:2170370
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1993
-
负责人:Maureen J Donlin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: